|
|||||
|
|
Anti‐factor IXa/X bispecific antibody (ACE910): hemostatic potency against ongoing bleeds in a hemophilia A model and the possibility of routine supplementation |
|
| Authors: | A. Muto K. Yoshihashi M. Takeda T. Kitazawa T. Soeda T. Igawa Y. Sakamoto K. Haraya Y. Kawabe M. Shima A. Yoshioka K. Hattori |
| Abstract: | |
| Keywords: | antibodies, catalytic factor VIII hemophilia A hemostasis therapeutics |